Get the app!
Back to Companies

Oncotelic Therapeutics, Inc.

OTLCOTCCIK: 0000908259

Recent Form 4 activity at Oncotelic Therapeutics, Inc. (OTLC) spans 14 filings across 6 insiders (all of them on the buy side). Purchases total $62.4K against $0 in sales — heavily weighted toward buying, for a net purchase of $62.4K. Trieu Vuong (CHAIRMAN AND CEO, Director, 10% Owner) is the most active by dollar volume, and the single largest transaction was $23.5K by Trieu Vuong. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.

Total Volume
$62.4K
Purchases
$62.4K
Sales
$0
Unique Insiders
6

Recent Insider Trades

14 loaded
Oct 30OTLC
Oncotelic Therapeutics, Inc.
Trieu VuongCHAIRMAN AND CEO, Director, 10% OwnerBuy$23.5K
Jul 14OTLC
Oncotelic Therapeutics, Inc.
Shah Amit B.CFOAward$0
Jul 14OTLC
Oncotelic Therapeutics, Inc.
Trieu VuongCHAIRMAN AND CEO, Director, 10% OwnerAward$0
Jul 14OTLC
Oncotelic Therapeutics, Inc.
MAIDA ANTHONY E IIIDIRECTOR AND CMO - TRANS. MED., DirectorAward$0
Jul 23OTLC
Oncotelic Therapeutics, Inc.
Fein Seymour HowardCRO/CMOAward$0
Jul 21OTLC
Oncotelic Therapeutics, Inc.
KING STEVEN WDirectorAward$0
Jul 14OTLC
Oncotelic Therapeutics, Inc.
Saund SaranCBOAward$0
Jul 2OTLC
Oncotelic Therapeutics, Inc.
Trieu VuongCHAIRMAN AND CEO, Director, 10% OwnerBuy$10.3K
Jun 22OTLC
Oncotelic Therapeutics, Inc.
Shah Amit B.CFOBuy$1.0K
Jun 24OTLC
Oncotelic Therapeutics, Inc.
Trieu VuongCHAIRMAN AND CEO, Director, 10% OwnerBuy$11.5K
Jun 17OTLC
Oncotelic Therapeutics, Inc.
Trieu VuongCHAIRMAN AND CEO, Director, 10% OwnerBuy$15.0K
Jan 26OTLC
Oncotelic Therapeutics, Inc.
Trieu VuongCHAIRMAN AND CEO, Director, 10% OwnerAward$0
Nov 19OTLC
Oncotelic Therapeutics, Inc.
Trieu VuongCHAIRMAN AND CEO, Director, 10% OwnerAward$0
Jul 10OTLC
Oncotelic Therapeutics, Inc.
Trieu VuongCHAIRMAN AND CEO, Director, 10% OwnerBuy$994

14 filings